Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
0.9073
-0.0739 (-7.53%)
At close: Sep 21, 2026, 4:00 PM EDT
0.9500
+0.0427 (4.71%)
After-hours: Sep 21, 2026, 5:59 PM EDT
Actuate Therapeutics Market Cap
Actuate Therapeutics has a market cap or net worth of $21.79 million as of September 21, 2026. Its market cap has decreased by -85.68% in one year.
Market Cap
21.79M
Enterprise Value
17.36M
1-Year Change
-85.68%
Ranking
Category
Stock Price
$0.91
ChartMarket Cap Chart
Since the IPO on August 13, 2024, Actuate Therapeutics's market cap has decreased from $152.13M to $21.79M, a decrease of -85.68%. That is a compound annual growth rate of -60.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 21.79M | -84.68% |
| Dec 31, 2025 | 142.25M | -8.50% |
| Dec 31, 2024 | 155.47M | 2.20% |
| Aug 13, 2024 | 152.13M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Psyence Biomedical | 25.27M |
| Radiopharm Theranostics | 24.67M |
| Cocrystal Pharma | 23.31M |
| Polyrizon | 23.13M |
| Estrella Immunopharma | 23.01M |
| Cellectar Biosciences | 22.50M |
| Atossa Therapeutics | 22.15M |
| GridAI Technologies | 22.02M |